Roberto De Ponti

Title: The Innovative Contributions of Roberto De Ponti

Introduction

Roberto De Ponti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable solutions for cancer treatment. With a total of 12 patents to his name, De Ponti's work has had a profound impact on medical therapies.

Latest Patents

One of his latest patents involves injectable ready-to-use solutions containing an antitumor anthracycline glycoside. This invention provides a sterile, pyrogen-free solution of an anthracycline glycoside, especially doxorubicin, which is crucial for the treatment of tumors in both humans and animals. The solution is designed to be administered by injection and consists of a physiologically acceptable salt of doxorubicin dissolved in a suitable solvent, maintaining a pH of 2.5 to 6.5. Another patent focuses on a sealed glass container that holds a stable, injectable, sterile, pyrogen-free doxorubicin anti-tumor composition. This solution also has a pH range of 2.5-3.5 and a concentration of doxorubicin from 0.1 to 100 mg/ml, ensuring its effectiveness in cancer treatment.

Career Highlights

Throughout his career, Roberto De Ponti has worked with prominent companies in the pharmaceutical industry. Notable among these are Pharmacia & Upjohn Company and Farmitalia Carlo Erba S.p.a. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

De Ponti has collaborated with several professionals in his field, including Gaetano Gatti and Diego Oldani. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Roberto De Ponti's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as an influential inventor. His patents reflect a commitment to improving medical therapies and patient outcomes.